In London, pharmaceutical stocks weighed on the blue-chip FTSE 100 index after Trump demanded that drug companies lower prices for American consumers. GSK fell 1.2% and AstraZeneca dipped 1.8%.

The NAV total return was short of the 0.8% of the trust's benchmark, the FTSE all-world index. However, the company's share price total return matched it at 0.8%, as the discount of its share price to ...

(Alliance News) - Melrose Industries PLC on Friday said all of its end markets were growing structurally amid rapidly increasing demand in the defence sector, as it increased its dividend amid a swing ...

While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

UK Indices - FTSE 100, FTSE 250, FTSE 350, FTSE All ShareClick on the Index names to view more information.